ttll3 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ttll3 antibody; zgc:136840 antibody; Tubulin monoglycylase TTLL3 antibody; EC 6.3.2.- antibody; Tubulin--tyrosine ligase-like protein 3 antibody
Target Names
ttll3
Uniprot No.

Target Background

Function
TTLL3 is a monoglycylase enzyme that modifies alpha- and beta-tubulin. It adds a single glycine residue to the gamma-carboxyl groups of specific glutamate residues within the C-terminal tail of tubulin, creating monoglycine side chains. This process is distinct from the elongation step of the polyglycylation reaction. TTLL3 exhibits a preference for glycylating beta-tail peptides over alpha-tail peptides. However, its preference shifts towards the alpha-tail as beta-tail glutamylation increases. TTLL3 competes with polyglutamylases for modification sites on the beta-tubulin substrate, resulting in an anticorrelation between glycylation and glutamylation reactions. Notably, TTLL3 is not involved in the elongation step of the polyglycylation reaction.
Gene References Into Functions
  1. TTLL3 proteins act as tubulin glycine ligases with chain-initiating activity. PMID: 19531357
Database Links
Subcellular Location
Cytoplasm, cytoskeleton. Cell projection, cilium. Cytoplasm, cytoskeleton, cilium axoneme. Cytoplasm, cytoskeleton, flagellum axoneme.

Q&A

What is TTLL3 and why is it important in cellular research?

TTLL3 is a monoglycylase enzyme responsible for initiating glycylation, a critical posttranslational modification (PTM) of tubulin. TTLL3 functions specifically by adding glycine residues to the C-terminal region of β-tubulin in axonemal structures. This modification plays a crucial role in regulating ciliary motility through the modulation of outer-arm dyneins, likely by neutralizing negative charges of glutamate residues at the C-terminus region of β-tubulin .

In Chlamydomonas research models, TTLL3 has been identified as the only monoglycylase expressed, making it an essential component for studying glycylation-dependent cellular processes . Its importance is evidenced by the complete absence of tubulin glycylation in TTLL3-deficient mutants, suggesting that this enzyme is solely responsible for initiating this specific tubulin modification in certain organisms .

What applications are TTLL3 antibodies validated for?

TTLL3 antibodies have been validated for several research applications:

  • Immunohistochemistry (IHC): Recommended dilutions typically range from 1:200-1:500

  • Enzyme-Linked Immunosorbent Assay (ELISA): Recommended dilutions ranging from 1:2000-1:10000

  • Western blotting: Particularly useful for detecting TTLL3 in flagellar and axonemal fractions

  • Indirect immunofluorescence microscopy: Used to visualize the distribution of TTLL3 and glycylated tubulin in cellular structures

Researchers should note that antibody performance can vary between applications, and optimization may be required for specific experimental systems.

What is the typical molecular weight of TTLL3 detected by antibodies in Western blot applications?

When using TTLL3-specific antibodies for Western blot analysis, researchers should expect to detect specific bands in the range between 150 and 250 kDa, although the predicted molecular weight of TTLL3 is approximately 146 kDa . Multiple antibodies targeting different amino-acid sequences of TTLL3 have confirmed this observation.

The discrepancy between predicted and observed molecular weights may result from post-translational modifications or protein-protein interactions that affect electrophoretic mobility. In Chlamydomonas research, Western blotting has shown that TTLL3 is predominantly detected in the flagellar fraction rather than the cytoplasmic fraction, suggesting compartmentalization of this enzyme .

What are the recommended storage conditions for TTLL3 antibodies?

For optimal preservation of TTLL3 antibodies, the following storage conditions are recommended:

Storage ParameterRecommendation
Temperature-20°C for long-term storage
Buffer CompositionOften supplied in solutions containing 50% glycerol, 0.01M PBS (pH 7.4), and preservatives such as 0.03% Proclin 300
AliquotingDivide into small aliquots to avoid repeated freeze-thaw cycles
HandlingAvoid exposure to heat and light

Proper storage ensures maintained antibody activity and specificity over time. Always consult the manufacturer's specific recommendations as storage conditions may vary between products.

How does TTLL3 localization differ across cellular structures, and what are the methodological considerations for accurate detection?

TTLL3 exhibits distinct localization patterns that require specific methodological approaches for accurate detection:

Subcellular Distribution of TTLL3:

  • TTLL3 is predominantly enriched in flagella and axonemal structures

  • Western blotting reveals that the majority of TTLL3 is localized to the axonemal fraction rather than the membrane+matrix fraction

  • TTLL3 associates relatively strongly with axonemal microtubules, similar to other tubulin modification enzymes like TTLL9

  • Immunostaining shows that in Chlamydomonas, TTLL3-dependent glycylation is restricted to axonemal microtubules and absent in cytoplasmic microtubules and basal bodies

Methodological Considerations:

  • Immunofluorescence detection of TTLL3 can be challenging due to its low expression level, requiring high-sensitivity detection methods

  • Peptide antibodies targeting distinct regions (N-terminal and C-terminal) of TTLL3 have been successfully utilized for detection

  • Axonemal fractionation techniques are essential for enriching samples for TTLL3 detection

  • The axonemal localization of TTLL3 depends on intraflagellar transport (IFT), suggesting that sample preparation methods that disrupt this transport may affect TTLL3 detection

What experimental approaches can be used to study the functional relationship between TTLL3, tubulin glycylation, and ciliary motility?

Research into the functional relationship between TTLL3, tubulin glycylation, and ciliary motility employs several specialized experimental approaches:

Genetic Manipulation Approaches:

  • CRISPR/Cas9-mediated gene editing to generate TTLL3-deficient mutants (e.g., ttll3(ex5) mutant in Chlamydomonas)

  • Creation of combined mutants lacking both TTLL3 and specific axonemal dyneins to dissect interaction pathways

Motility Assessment Techniques:

  • Swimming velocity tracking using dark-field microscopy with digital camera recording (30 fps)

  • Microtubule sliding velocity measurements during axonemal disintegration using protease-induced sliding assays

  • Quantitative analysis of flagellar waveforms and beat frequencies

Structural Analysis Methods:

  • Double staining of frayed axonemes to investigate the specific localization of glycylation on outer doublet versus central-pair microtubules

  • Isolation and analysis of regenerated flagella to study the dynamics of TTLL3 transport and activity during flagellar assembly

These techniques have revealed that TTLL3-dependent glycylation specifically affects the outer-doublet microtubules but not the central-pair microtubules, and that the absence of glycylation decreases swimming velocity through effects on outer-arm dyneins .

What controls and validation steps should be included when using TTLL3 antibodies in research?

When using TTLL3 antibodies, researchers should implement comprehensive controls and validation steps:

Essential Controls:

  • Positive Controls: Include samples known to express TTLL3, such as flagellar/ciliary fractions from wild-type organisms

  • Negative Controls:

    • TTLL3 knockout/mutant samples (e.g., ttll3(ex5) strain)

    • Primary antibody omission

    • Isotype controls

  • Specificity Controls:

    • Use of multiple antibodies targeting different epitopes of TTLL3

    • Pre-absorption with immunizing peptide

    • Western blot confirmation of specific banding pattern

Validation Steps:

  • Confirm antibody specificity by demonstrating absence of signal in TTLL3-deficient samples

  • Verify expected subcellular localization (predominantly in flagella/cilia rather than cytoplasm)

  • Demonstrate expected molecular weight bands in Western blot (150-250 kDa range)

  • Correlate antibody staining with functional outcomes (e.g., changes in glycylation levels or motility phenotypes)

  • Compare results using different antibody clones or sources

How do fixation and sample preparation methods affect TTLL3 antibody performance in immunostaining?

The choice of fixation and sample preparation methods significantly impacts TTLL3 antibody performance:

Fixation Considerations:

  • Paraformaldehyde fixation (typically 4%) preserves antigenicity while maintaining cellular architecture

  • Methanol fixation may better expose certain epitopes but can destroy some cellular structures

  • Glutaraldehyde should be used at low concentrations (<0.5%) if needed, as higher concentrations may mask TTLL3 epitopes

Sample Preparation for Axonemal Studies:

  • For nuclear-flagellar apparatus (NFAp) isolation, cell wall removal using autolysin treatment followed by gentle agitation at specific temperatures (e.g., 40°C for 30 minutes) has proven effective

  • For axoneme isolation, a combination of detergent treatment and mechanical disruption preserves axonemal structures while removing membranes

  • For frayed axoneme preparation (to distinguish outer doublets from central pair microtubules), controlled protease digestion is recommended

Critical Permeabilization Parameters:

  • Detergent type and concentration affect antibody accessibility (e.g., 0.1-0.5% Triton X-100 for membrane permeabilization)

  • Permeabilization duration must be optimized to balance antibody access with preservation of axonemal structures

  • Temperature during permeabilization affects efficiency and should be standardized

Researchers should test multiple fixation and permeabilization conditions when establishing TTLL3 immunostaining protocols for their specific experimental system.

How can researchers differentiate between the roles of TTLL3 and other tubulin modification enzymes?

Differentiating between TTLL3 and other tubulin modification enzymes requires specific experimental strategies:

Comparative Analysis Approaches:

  • Generate and compare single mutants lacking specific modification enzymes (e.g., ttll3(ex5) for glycylation vs. ttll9(ex8) for glutamylation)

  • Create double mutants to study potential interplay between different modifications

  • Use specific antibodies that recognize distinct tubulin modifications (e.g., gly-pep1 for glycylation, polyE for polyglutamylation)

Functional Dissection Strategies:

  • Conduct sliding disintegration assays to assess how different modifications affect microtubule-motor interactions

  • Combine mutations in modification enzymes with mutations in axonemal components (e.g., dynein arms) to identify specific functional pathways

  • Compare swimming behaviors and waveform characteristics between different modification-deficient mutants

Molecular Analysis Methods:

  • Perform rescue experiments by reintroducing wild-type or mutated forms of modification enzymes

  • Use domain-swapping approaches to identify functional regions specific to each enzyme

  • Analyze crystal structures to understand the structural basis for enzymatic specificity

Research has shown that while TTLL3 deficiency completely abolishes glycylation without affecting most other modifications, TTLL9 deficiency primarily affects polyglutamylation . These distinctions help map the specific contributions of each enzyme to ciliary function.

What are the key methodological considerations for quantifying TTLL3 levels during flagellar regeneration experiments?

Quantifying TTLL3 levels during flagellar regeneration requires careful methodological considerations:

Experimental Design for Regeneration Studies:

  • Use standardized methods for deflagellation (e.g., pH shock treatment)

  • Establish consistent regeneration conditions (temperature, media, timing)

  • Collect samples at multiple timepoints to capture dynamic changes

Quantification Approaches:

  • Western blotting with normalization to total protein content

  • Consideration of flagellar length at different regeneration stages

  • Calculation of TTLL3 content on a per-flagellum basis rather than solely by protein concentration

Analytical Considerations:

  • Account for the enrichment of TTLL3 during regeneration (approximately 3x higher in regenerating vs. steady-state flagella)

  • Adjust for differences in flagellar length (regenerating flagella at 30 minutes are approximately half the length of steady-state flagella)

  • Consider the implications of increased TTLL3 transport frequency during flagellar assembly

Flagellar StateRelative TTLL3 Level (normalized to total protein)Approximate Flagellar LengthTTLL3 Content per Flagellum
Steady-stateFull length
30-min Regeneration~3×~50% of full length~1.5×

This data suggests that TTLL3 transport into flagella increases significantly during regeneration, with approximately 1.5 times more TTLL3 per flagellum during active assembly compared to steady-state conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.